Zanzalintinib in Combination With Ipilimumab and Nivolumab in Patients With Metastatic Soft Tissue Sarcoma
Clinical trial NCT06968988 · RECRUITING
Trial details
- NCT number
- NCT06968988
- Sponsor
- Washington University School of Medicine
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-05
- Primary completion
- 2029-02-12
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.